Skip to search.
 TSX Up 0.03% TSX Ventures Up 1.56%

ZIOPHARM Oncology, Inc. (ZIOP)

-NasdaqCM
5.17 Down 0.25(4.61%) Aug 25, 4:00PM EDT
Prev Close:5.42
Open:5.40
Bid:4.82 x 400
Ask:5.75 x 1000
1y Target Est:13.00
Beta:1.91351
Earnings Date:Oct 31 - Nov 4 (Est.)
Day's Range:4.92 - 5.50
52wk Range:4.45 - 14.93
Volume:2,248,534
Avg Vol (3m):2,265,410
Market Cap:674.66M
P/E (ttm):N/A
EPS (ttm):-1.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
ZIOPDown 4.61%674.66M
IMGNDown 2.36%252.52M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):94.89
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.34
Quarterly EPS Est (Sep-16) :-0.11
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ZIOPHARM Oncology, Inc., a biotechnology company, focuses on acquiring, developing, and commercializing a portfolio of cancer therapies that address unmet medical needs through synthetic immuno-oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback